Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

PL EN


Preferences help
enabled [disable] Abstract
Number of results
1996 | 37 | 4 | 385-392

Article title

Increased constitutional chromosome sensitivity to bleomycin in patients with hereditary non polyposis colorectal cancer (HNPCC)

Title variants

Languages of publication

EN

Abstracts

EN
It has been suggested that mutagen sensitivity is a constitutional factor which may be useful in identification of patients with an increased risk for the development of tumors. In this study, the chromosome sensitivity to bleomycin was measured according to HSU in patients with hereditary non polyposis colorectal cancer (HNPCC), sporadic colorectal cancer and in control persons with no tumor history in family. In vitro lymphocytes were exposed to bleomycin according to HSU and chromosomal damage was quantified by scoring breaks of 100 cells. A significant difference (P < 0.01) in the mean number of breaks per cell (b/c) was found between HNPCC patients (0.59_0.14; n = 12; mean age 55.4 yrs) and control individuals (0.35_0.13: n = 12; mean age 55.8 yrs). In contrast, patients with sporadic colorectal cancer showed a mean b/c value of 0.43_0.14 (n = 14; mean age 63.4 yrs) which was not significantly higher than that in control individuals for this group (0.42 _0.15; n = 14; mean age 63.1 yrs). Selenium protected lymphocytes of HNPCC patients against bleomycin activity in vitro.

Keywords

Discipline

Year

Volume

37

Issue

4

Pages

385-392

Physical description

Contributors

author
author
author

References

Document Type

article

Publication order reference

J. Kladny, Department of General and Vascular Surgery, Medical Academy, Powstancow Wlkp. 72, 70-111 Szczecin, Poland.

Identifiers

YADDA identifier

bwmeta1.element.element-from-psjc-c236c113-c52d-315b-bfac-bfb6133abd50
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.